MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 03-03-2026
Agilent Technologies Cash and Cash Equivalents 2011-2026 | A
Annual Cash and Cash Equivalents Agilent Technologies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.48 B | 1.44 B | 1.38 B | 2.25 B | 2.68 B | 2.29 B | 2 B | 3.03 B | 2.68 B | 2.35 B | 3.53 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.53 B | 1.38 B | 2.28 B |
Quarterly Cash and Cash Equivalents Agilent Technologies
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.76 B | 1.79 B | 1.54 B | 1.47 B | 1.33 B | 1.78 B | 1.75 B | 1.18 B | 1.11 B | 1.05 B | - | 1.19 B | 1.33 B | 1.48 B | 1.43 B | 1.48 B | 1.23 B | 1.44 B | 1.44 B | 1.32 B | 2.06 B | 1.38 B | 1.38 B | 1.38 B | 2.89 B | 2.25 B | 2.25 B | 2.25 B | 2.24 B | 2.68 B | 2.68 B | 2.68 B | 1.93 B | 2.29 B | 2.29 B | 2.29 B | 2.12 B | 2 B | 2 B | 2 B | 2.74 B | 2.22 B | 2.22 B | 2.22 B | 2.45 B | 2.68 B | 2.68 B | 2.68 B | 3.66 B | 2.35 B | 2.35 B | 2.35 B | 2.64 B | 3.53 B | 3.53 B | 3.53 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.66 B | 1.05 B | 2.07 B |
Cash and Cash Equivalents of other stocks in the Diagnostics research industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
59.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
34.9 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Co-Diagnostics
CODX
|
11.9 M | $ 1.72 | 2.99 % | $ 2.29 M | USA |
 |
Aspira Women's Health
AWH
|
1.76 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
12.9 M | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
120 M | $ 25.0 | 2.21 % | $ 694 M | USA |
 |
Chembio Diagnostics
CEMI
|
18.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
7.7 M | - | - | $ 9.42 M |  Israel |
 |
CareDx, Inc
CDNA
|
65.4 M | $ 21.37 | 0.66 % | $ 1.14 B | USA |
 |
DermTech
DMTK
|
36.7 M | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
52.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
956 M | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
55.1 M | $ 16.33 | 0.12 % | $ 494 M | USA |
 |
Illumina
ILMN
|
1.13 B | $ 128.0 | 0.09 % | $ 20.4 B | USA |
 |
Global Cord Blood Corporation
CO
|
6.66 B | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
11.7 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
176 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
214 M | $ 171.98 | 1.3 % | $ 8.52 B | USA |
 |
Guardant Health
GH
|
378 M | $ 88.84 | -0.08 % | $ 11.1 B | USA |
 |
Lantheus Holdings
LNTH
|
359 M | $ 84.31 | -0.03 % | $ 5.69 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
12.2 M | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
157 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
2.5 M | $ 1.98 | -2.37 % | $ 8.76 M | USA |
 |
Medpace Holdings
MEDP
|
497 M | $ 412.77 | 0.54 % | $ 11.9 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.79 B | $ 27.63 | 0.58 % | $ 20 B |  Niderland |
 |
Motus GI Holdings
MOTS
|
4.96 M | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
598 M | - | - | $ 10.6 B | Niderland |
 |
Senseonics Holdings
SENS
|
40.2 M | $ 7.05 | - | $ 294 M | USA |
 |
Neogen Corporation
NEOG
|
129 M | $ 9.6 | 0.58 % | $ 2.08 B | USA |
 |
Biomerica
BMRA
|
2.4 M | $ 2.12 | -0.93 % | $ 4.87 M | USA |
 |
National Research Corporation
NRC
|
4.14 M | $ 17.33 | 0.55 % | $ 388 M | USA |
 |
ICON Public Limited Company
ICLR
|
752 M | $ 101.21 | -0.94 % | $ 8.35 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
532 M | $ 263.81 | 0.03 % | $ 21.9 B | USA |
 |
Thermo Fisher Scientific
TMO
|
9.85 B | $ 473.8 | 0.9 % | $ 179 B | USA |
 |
Celcuity
CELC
|
166 M | $ 125.71 | 3.87 % | $ 5.88 B | USA |
 |
Trinity Biotech plc
TRIB
|
5.17 M | $ 0.64 | -1.34 % | $ 61.9 M | Irlanda |
 |
OpGen
OPGN
|
1.31 M | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
160 M | $ 8.41 | 1.45 % | $ 1.08 B | USA |
 |
Twist Bioscience Corporation
TWST
|
183 M | $ 61.16 | 0.36 % | $ 3.66 B | USA |
 |
Myriad Genetics
MYGN
|
150 M | $ 4.91 | 2.72 % | $ 455 M | USA |
 |
Natera
NTRA
|
466 M | $ 206.02 | 1.11 % | $ 20.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
420 M | $ 196.49 | 0.14 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
257 M | - | - | $ 21.2 M | USA |
 |
PerkinElmer
PKI
|
920 M | - | -0.91 % | $ 14.7 B | USA |
 |
Organovo Holdings
ONVO
|
11.3 M | - | -2.3 % | $ 19.4 M | USA |